\-\ Texto\\:\\ \ \(0\)\
\-\ as\\ above\\.\ \(7\)\
\-\ serum\\ t\\.\\ gondii\\ antibodies\\ \\-\\ neg\ \(0\)\
\-\ csf\\ ebv\\ titers\\ \\-\\ positive\ \(0\)\
\-\ cd4\\ count\\ \\-\\ 67\ \(0\)\
\-\ steroids\\ and\\ radiotherapy\\.\\ \\ follow\\-up\\ images\\ obtained\\ one\\ week\\ later\\ demonstrated\\ no\\ change\\.\ \(0\)\
\-\ flair\\ images\\ demonstrate\\ massive\\ edema\\ in\\ the\\ left\\ cerebral\\ cortex\\ with\\ a\\ mixed\\ signal\\ lesion\\.\\ \\ mass\\ effect\\ again\\ is\\ noted\\ in\\ the\\ sagittal\\ t1\\ weighted\\ image\\,\\ impressing\\ upon\\ the\\ cingulate\\ gyrus\\.\\ \\ post\\-gadolinium\\ enhanced\\ t1\\ weighted\\ axial\\ images\\ demonstrate\\ a\\ ring\\ enhancing\\ lesion\\ with\\ hypointense\\ central\\ region\\ with\\ maximal\\ dimensions\\ of\\ 2\\.6\\ x\\ 3\\.1\\ cm\\.\ \(0\)\
\-\ primary\\ cns\\ lymphoma\\ in\\ a\\ patient\\ with\\ aids\ \(0\)\
\-\ toxoplasmosis\ \(14\)\
\-\ 29\\ year\\ old\\ male\\ with\\ aids\\ presenting\\ with\\ progressively\\ worsening\\ right\\ paresis\\,\\ the\\ leg\\ being\\ more\\ affected\\ than\\ the\\ arm\\.\\ \\ patient\\ is\\ not\\ on\\ haart\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ aids\\:\\ 0\\.0842485436404216\ \(0\)\
\-\ impressing\\:\\ 0\\.06395567908194136\ \(0\)\
\-\ haart\\:\\ 0\\.06395567908194136\ \(0\)\
\-\ gondii\\:\\ 0\\.06076304043542038\ \(0\)\
\-\ weighted\\:\\ 0\\.05851420466365826\ \(0\)\
\-\ cingulate\\:\\ 0\\.05674079142938896\ \(0\)\
\-\ cd4\\:\\ 0\\.05409140373945815\ \(0\)\
\-\ paresis\\:\\ 0\\.05409140373945815\ \(0\)\
\-\ titers\\:\\ 0\\.05303997545107608\ \(0\)\
\-\ gyrus\\:\\ 0\\.05211254997346676\ \(0\)\
\-\ antibodies\\:\\ 0\\.048633551924025506\ \(0\)\
\-\ ebv\\:\\ 0\\.048633551924025506\ \(0\)\
\-\ t\\.\\:\\ 0\\.04665469815803412\ \(0\)\
\-\ dimensions\\:\\ 0\\.04582508779852368\ \(0\)\
\-\ 3\\.1\\:\\ 0\\.045440913277504526\ \(0\)\
\-\ 2\\.6\\:\\ 0\\.04438948498912246\ \(0\)\
\-\ maximal\\:\\ 0\\.04375922744838595\ \(0\)\
\-\ \\-\\:\\ 0\\.043269176189961345\ \(0\)\
\-\ toxoplasmosis\\:\\ 0\\.04317570010859287\ \(0\)\
\-\ t1\\:\\ 0\\.042653473011405416\ \(0\)\
\-\ post\\-gadolinium\\:\\ 0\\.04188197529527573\ \(0\)\
\-\ neg\\:\\ 0\\.041196846342601484\ \(0\)\
\-\ radiotherapy\\:\\ 0\\.04098110638836436\ \(0\)\
\-\ 67\\:\\ 0\\.040367235983091034\ \(0\)\
\-\ images\\:\\ 0\\.038722769101165844\ \(0\)\
\-\ massive\\:\\ 0\\.038454273946788756\ \(0\)\
\-\ progressively\\:\\ 0\\.0361890607778771\ \(0\)\
\-\ 29\\:\\ 0\\.03510873698643233\ \(0\)\
\-\ cns\\:\\ 0\\.03443202494075734\ \(0\)\
\-\ serum\\:\\ 0\\.03247378379320752\ \(0\)\
\-\ again\\:\\ 0\\.03233061592641074\ \(0\)\
\-\ hypointense\\:\\ 0\\.03191609833991135\ \(0\)\
\-\ steroids\\:\\ 0\\.0316514006170847\ \(0\)\
\-\ ring\\:\\ 0\\.03127032549218824\ \(0\)\
\-\ demonstrate\\:\\ 0\\.03096775025721324\ \(0\)\
\-\ flair\\:\\ 0\\.030847863181225094\ \(0\)\
\-\ mixed\\:\\ 0\\.029550577881413635\ \(0\)\
\-\ count\\:\\ 0\\.02925710233182913\ \(0\)\
\-\ affected\\:\\ 0\\.02911436702007672\ \(0\)\
\-\ cortex\\:\\ 0\\.02879104822639346\ \(0\)\
\-\ enhanced\\:\\ 0\\.02879104822639346\ \(0\)\
\-\ arm\\:\\ 0\\.028181704418398023\ \(0\)\
\-\ csf\\:\\ 0\\.028098380722881986\ \(0\)\
\-\ upon\\:\\ 0\\.027500066494709367\ \(0\)\
\-\ presenting\\:\\ 0\\.02742361913937897\ \(0\)\
\-\ lesion\\:\\ 0\\.0274103185196922\ \(0\)\
\-\ sagittal\\:\\ 0\\.026837375216585666\ \(0\)\
\-\ worsening\\:\\ 0\\.026491968270872423\ \(0\)\
\-\ leg\\:\\ 0\\.02645824652447871\ \(0\)\
\-\ change\\:\\ 0\\.026226153468313723\ \(0\)\
\-\ above\\:\\ 0\\.024660934304156036\ \(0\)\
\-\ later\\:\\ 0\\.02429463496844822\ \(0\)\
\-\ obtained\\:\\ 0\\.023920205517668047\ \(0\)\
\-\ effect\\:\\ 0\\.023823293331253895\ \(0\)\
\-\ being\\:\\ 0\\.023447149423626443\ \(0\)\
\-\ cerebral\\:\\ 0\\.023310602376095047\ \(0\)\
\-\ week\\:\\ 0\\.022850515104946678\ \(0\)\
\-\ x\\:\\ 0\\.022197372719271472\ \(0\)\
\-\ central\\:\\ 0\\.022138829581574482\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.021890055050722376\ \(0\)\
\-\ positive\\:\\ 0\\.021833744805386746\ \(0\)\
\-\ enhancing\\:\\ 0\\.021101996321927236\ \(0\)\
\-\ image\\:\\ 0\\.02101723752990237\ \(0\)\
\-\ primary\\:\\ 0\\.019932159550359815\ \(0\)\
\-\ demonstrated\\:\\ 0\\.01974346442879502\ \(0\)\
\-\ lymphoma\\:\\ 0\\.019229910507003824\ \(0\)\
\-\ axial\\:\\ 0\\.0192030824887234\ \(0\)\
\-\ edema\\:\\ 0\\.019030893617569218\ \(0\)\
\-\ region\\:\\ 0\\.019004734072750492\ \(0\)\
\-\ one\\:\\ 0\\.018234105380398772\ \(0\)\
\-\ cm\\:\\ 0\\.01804689856548808\ \(0\)\
\-\ signal\\:\\ 0\\.017740742758053374\ \(0\)\
\-\ than\\:\\ 0\\.017630305944238377\ \(0\)\
\-\ more\\:\\ 0\\.01682815991584383\ \(0\)\
\-\ noted\\:\\ 0\\.01594819833427239\ \(0\)\
\-\ patient\\:\\ 0\\.013489636707344693\ \(0\)\
\-\ male\\:\\ 0\\.012166972739271443\ \(0\)\
\-\ as\\:\\ 0\\.010177775636961636\ \(0\)\
\-\ in\\:\\ 0\\.00995426527890366\ \(0\)\
\-\ not\\:\\ 0\\.009722981667259333\ \(0\)\
\-\ a\\:\\ 0\\.00936849925555751\ \(0\)\
\-\ mass\\:\\ 0\\.009357960684626493\ \(0\)\
\-\ is\\:\\ 0\\.008854972887948434\ \(0\)\
\-\ left\\:\\ 0\\.0075283879470308245\ \(0\)\
\-\ year\\:\\ 0\\.0075283879470308245\ \(0\)\
\-\ right\\:\\ 0\\.007099462276459974\ \(0\)\
\-\ old\\:\\ 0\\.006889248794190981\ \(0\)\
\-\ no\\:\\ 0\\.006775150792943323\ \(0\)\
\-\ on\\:\\ 0\\.005699929231223843\ \(0\)\
\-\ with\\:\\ 0\\.005527756350703452\ \(0\)\
\-\ the\\:\\ 0\\.005442885224552197\ \(0\)\
\-\ \\,\\:\\ 0\\.0042631506380675175\ \(0\)\
\-\ \\.\\:\\ 0\\.002236191250226537\ \(0\)\
\-\ and\\:\\ 0\\.00141739374592298\ \(0\)\
\-\ of\\:\\ 0\\.0009173527621888852\ \(0\)\
